Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2005-08-16
2005-08-16
Wehbé, Anne M. (Department: 1632)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S093300, C424S093710, C424S093720, C424S093200, C424S093100, C435S325000, C435S320100, C435S455000, C514S04400A
Reexamination Certificate
active
06929792
ABSTRACT:
The invention provides isolated dendritic cells genetically modified to express a selectin polypeptide, optionally treated with activated platelets or membrane microparticles thereof. The invention also provides isolated platelet modified dendritic cells. Methods for delivering the modified dendritic cells to peripheral lymph nodes and methods for using the modified dendritic cells to stimulate immune responses also are provided. Vaccine compositions containing the modified dendritic cells also are provided.
REFERENCES:
patent: WO 98/46083 (1998-10-01), None
Miller et. al.; Targeted vectors for gene therapy, 1995, FASEB J> 9: 190-199.
Deonarain, Ligand-targeted receptor-mediated vectors for gene delivery, 1998, Exp. Opin. Ther. Patents 8(1): 53-69.
Orkin et al.; Report and Recommendations of the Panel to Assess the N IH Investment in Research on Gene Therapy, 1995.
Ross et al.; Gene Therapy in the United States: A Five-Year Status Report, 1996, Human Gene Therapy 7: 1781-1790.
Bondanza et al. (1998) J. Leuk. Biol., Suppl. 2, p. 70, abstract F17.
Whiss et al. (1998) Cell Adh. Comm., vol. 6 (4), 289-300.
Stoddart et al.,J. Immunol.157:5653-5659, 1996.
Von Andrian et al.,Cell82:989-999, 1995.
Stein et al.J. Exp. Med.189:37-49, 1999.
Lawrence and Springer,Cell65:859-873, 1991.
Diacovo et al.,Science, 273: 252-255, 1996.
Von Andrian,Microcirculation3:287-300, 1996.
Mayordomo et al.,Nature Med. 1:1297-1302, 1995.
Ory et al.,Proc. Natl. Acad. Sci. USA93:11400-11406, 1996.
Klein et al., Blood 94(10):398a (1999).
Robert et al., J of Invest. Derm. 112(4):524 (1994).
Diacovo et al., Blood 90(10):567a (1997).
Andrian Ulrich Von
Kupper Thomas S.
Robert Caroline
The Brigham & Women's Hospital, Inc.
The CBR Institute for Biomedical Research, Inc.
Wehbe Anne M.
Wolf Greenfield & Sacks P.C.
LandOfFree
Modified dendritic cells and use therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified dendritic cells and use therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified dendritic cells and use therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3512216